SCHEMBL13625550

SCHEMBL13625550

COC(=O)Nc1cc2c3c(c1)[C@](C)(c1cccnc1)CCN3CC[C@@]2(C)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.39
ACHE P22303 1/20 0.38
SMPD3 Q9NY59 1/20 0.38
PTPN11 Q06124 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 3/20 0.36
GRIN2B Q13224 1/20 0.36
ALDH1A1 P00352 3/20 0.35
POLB P06746 1/20 0.35
KIF11 P52732 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
FSHR P23945 1/20 0.35
MCHR1 Q99705 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899276 1.00 CYP2D6 (0.42) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL13625552 1.00 CYP2D6 (0.42) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL8988318 0.97 CYP2D6 (0.41) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL8988315 0.97 CYP2D6 (0.41) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL8988311 0.97 CYP2D6 (0.41) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL8988293 0.87 EPHX2 (0.42) CYP2D6HPGDSMN1; SMN2LMNAACHE
SCHEMBL14899279 0.87 HIF1A (0.39) CYP2D6HPGDACHESMPD3MEN1
SCHEMBL8988202 0.87 FSHR (0.44) HPGDSMN1; SMN2ACHEMEN1KMT2A
SCHEMBL2392497 0.87 FSHR (0.44) HPGDSMN1; SMN2ACHEMEN1KMT2A
SCHEMBL2389637 0.87 FSHR (0.44) HPGDSMN1; SMN2ACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431702-B2 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds ALLERGAN, INC. (US) 2013-04-30 US disclosed
WO-2009137681-A1 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-IJ] QUINOLINE COMPOUNDS ALLERGAN, INC. (US) 2009-11-12 WO disclosed